Related Experiment Video

Updated: Jul 3, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Promising newer molecular-targeted therapies in head and neck cancer

Lili X Wang1, Mark Agulnik

  • 1Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.

Drugs
|August 7, 2008
PubMed

Insights

New molecular-targeted and biological therapies are needed for head and neck cancer (HNC). Research is exploring therapies like epidermal growth factor receptor (EGFR) inhibition and anti-angiogenesis agents for advanced HNC.

Area of Science:

  • Oncology
  • Cancer Research
  • Head and Neck Oncology

Background:

  • Head and neck cancer (HNC) is a significant global health concern, representing the fifth most common cancer worldwide.
  • Squamous cell carcinoma of the upper aerodigestive tract accounts for 90% of HNC diagnoses.
  • Current therapeutic options yield suboptimal outcomes for patients with locally advanced, recurrent, or metastatic HNC.

Purpose of the Study:

  • To highlight the urgent need for novel treatment strategies in head and neck cancer, particularly for advanced stages.
  • To review emerging molecular-targeted and biological therapies showing promise in HNC treatment.
  • To discuss the ongoing investigation of therapies targeting the epidermal growth factor receptor (EGFR) and anti-angiogenesis agents.

Main Methods:

  • Review of existing clinical trial data on targeted therapies for HNC.
  • Exploration of novel therapeutic agents, including EGFR inhibitors and anti-angiogenesis agents.
  • Analysis of the potential role of these new therapies in improving patient outcomes.

Main Results:

  • Clinical trials support the use of epidermal growth factor receptor (EGFR) inhibition in metastatic and locally advanced HNC.
  • Numerous trials are actively investigating the efficacy of new targeted therapies.
  • The potential of anti-angiogenesis agents in HNC treatment is under evaluation.

Conclusions:

  • Advanced head and neck cancer necessitates innovative therapeutic approaches.
  • Molecular-targeted and biological therapies, including EGFR inhibition and anti-angiogenesis agents, represent promising avenues for HNC treatment.
  • Further clinical trials are crucial to establish the definitive role of these novel therapies in improving survival and outcomes for HNC patients.

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...